IZI Medical
Private Company
Total funding raised: $2.5M
Overview
IZI Medical is a long-established, commercial-stage medical device company focused on interventional oncology and spine procedures. The company operates as a developer, manufacturer, and distributor of a diverse portfolio of consumable devices, selling to over 2,000 domestic customers and across 25 countries internationally. Its strategy centers on partnering with clinicians to innovate in essential but often overlooked procedural areas, and it is supported by the resources of its parent company, Halma plc. IZI's core products include the Quick-Core® Auto Biopsy Needle, Vertefix® MV bone cement, and the Blazer-C Vertebral Augmentation System.
Technology Platform
Expertise in designing and manufacturing minimally invasive, consumable medical devices for image-guided procedures, with focus on enhanced visualization (e.g., tracking beads), procedural reliability, and integrated system solutions.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
IZI competes in segmented markets against large, diversified players like Medtronic, Stryker, and Johnson & Johnson DePuy Synthes in spine augmentation, and against BD, Cook Medical, and Argon Medical in the biopsy device space. Its competitive advantage lies in its specialized, physician-collaborative approach and integrated procedural solutions, rather than in competing on scale alone.